The advertisement promotes Rexulti (brexpiprazole) as the only FDA-approved treatment for agitation associated with dementia due to Alzheimer's disease, providing information on its use and prescribing details.
Creative Information
| CID: | 0185f734-09c1-4e91-a63b-d52c741010c1 |
| CRID: | 82_6689-817015 |
| Domain: | rexulti.com |
| Seat: | PP |
| Size: | 300x250 |
| Bid: | $1.06 |
| Timestamp: | 11/13/2025, 2:51:18 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/13/2025, 4:10:39 PM | 6.92s | |
| adomain_analysis | success | 11/13/2025, 6:41:28 PM | 2.75s | |
| adomain_capture | success | 11/13/2025, 6:40:46 PM | 0.08s | |
| ad_render | success | 11/13/2025, 4:10:32 PM | 24.80s | |
| brand_mapping | success | 11/13/2025, 2:51:18 PM | 0.11s | |
Analysis Results
Ad Format: banner
Brands: Rexulti
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 300x250 | ||||||||||||||||||||||
| Data Transferred: | 1987.45 KB | ||||||||||||||||||||||
| Render Time: | 9.36 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1987.53 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives


